This study used phaseolamin as amylase inhibitor to investigate the effects of a reduced amylase activity on digestion of starch in the duodenum, jejunum and ileum in human beings.
Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans.
Layer, P.